President Mung Chiang joins industry leaders during SXSW to discuss the university’s role in shaping the future of pharma
Purdue University’s position as a key player in the future of the pharmaceutical industry will be spotlighted at the Fast Company Grill on Saturday (March 8) during the annual South by Southwest (SXSW) Conference & Festivals in Austin, Texas.
President Mung Chiang will take the stage at the Brands That Matter panel titled “Innovating What Matters: Driving Pharma Forward,” along with Sean Bruich, senior vice president of artificial intelligence and data at Amgen, and Tatyana Kanzaveli, chief operating officer of Open Health Network. The panel will examine the transformation of the pharmaceutical industry through AI, strategic collaboration and next-generation innovation while discussing the importance of cross-industry partnerships to accelerate medical breakthroughs.
Purdue has emerged as a global leader in pharmaceutical and biotech innovation, collaborating with corporate leaders and pharma partners to tackle critical issues facing the industry. In January, in collaboration with Eli Lilly and Company and Merck & Co. Inc., Purdue launched the Young Institute Pharmaceutical Manufacturing Consortium, a collaborative effort to pioneer advances in making medicines. The consortium will elevate and enhance pharmaceutical and biopharmaceutical advanced manufacturing by developing disruptive innovative technologies, autonomous systems, and smart AI and digital technology, together with industrially relevant education and training for the next generation of scientific leaders and researchers. The collaboration also underscores a commitment to onshoring pharmaceutical manufacturing while bolstering domestic production.
Purdue also teamed with Lilly this past August to form the Eli Lilly and Company and Purdue University Research Alliance Center, which serves as an essential hub for collaborative exploration of new technologies that enhance every phase of pharmaceutical research, from discovery to delivery.
Pharmaceutical manufacturing is a key component of Purdue’s One Health initiative, which advances knowledge and innovation related to animal, human and environmental health and well-being through novel interdisciplinary research and industry partnerships.
The panel featuring Chiang and Purdue’s overall presence at SXSW serve as a key starting point for the university’s enterprise marketing campaign. Supported by Purdue Brand Studio, the university’s central marketing and communications team and its own in-house agency, SXSW provides a major platform to amplify Purdue’s renowned reputation while showcasing its thought leadership and global impact across industries.
Discover the latest trends and insights—explore the Business Insights Journal for up-to-date strategies and industry breakthroughs!
